4D Biomaterials | $4,373,097 | (Jul 26, 2024)
Micropep Technologies | $29,000,000 | (Jul 26, 2024)
TRiCares GmbH | $50,000,000 | (Jul 26, 2024)
Certified by Founder
Lodge
Mable | Neurolytic Healthcare
start up
United States
- San Francisco, California
- 27/07/2022
- Seed
- $3,200,000
Migraines are heritable. Uncover the link between your genetics and migraines to help prevent your migraine in advance and get medication delivered directly to your door.
- Industry Hospital & Health Care
- Website https://www.trymable.com/?utm_source=linkedin&utm_medium=social&utm_campaign=custom_button
- LinkedIn https://www.linkedin.com/company/mable-migraine-relief/
Related People
Roman RothaermelCo Founder
United Kingdom -
London, England
Before founding Mable, I was a researcher at the University of Oxford working at the intersection between neuroscience, data science and pharmacology. Today at Mable, we're using data-driven approaches to fight neurological conditions starting with migraines - a problem that affects 12% of the population and is in urgent need of innovation in care quality and delivery mechanisms.
SirenOpt | $6,600,000 | (Jul 26, 2024)
Jarvis | $2,315,016 | (Jul 26, 2024)
Archera | $17,000,000 | (Jul 26, 2024)
Noded Ai | $4,000,000 | (Jul 26, 2024)
NAVIGANTIS | $12,000,000 | (Jul 26, 2024)
GEOH | $3,000,000 | (Jul 26, 2024)
Addionics | $39,000,000 | (Jul 26, 2024)
Fractile | $15,000,000 | (Jul 26, 2024)
HASH | $10,000,000 | (Jul 26, 2024)